Answer
Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS), which can be life-threatening or fatal, have been reported post-marketing with Esbriet (pirfenidone).
Sources for this answer
- Esbriet 267 mg, 801 mg Film-coated TabletsRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 14Document updated
Sources checked